20 Participants Needed
Indiana University logo

Inspiratory Muscle Training for Exercise-Induced Asthma

(IMT_EIB Trial)

Recruiting in Bloomington (>99 mi)
AS
TM
Overseen ByTim Mickleborough, Ph.D.
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
Must be taking: Short-acting beta-2-agonists
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Due to the lack of studies examining the impact of inspiratory muscle training (IMT) on the severity of exercise-induced bronchoconstriction (EIB) and exercise performance, the specific aim of this study is to assess the efficacy of flow-resistive IMT on EIB severity and symptoms, short-acting beta-2-agonist medication use, operating lung volumes, respiratory and limb locomotor muscle deoxygenation during constant-load cycling exercise, exertional dyspnea, and cycling time-trial performance.

Will I have to stop taking my current medications?

Yes, you will need to stop taking certain medications. The trial excludes participants who are currently taking asthma maintenance medications, SSRIs, ADHD medication, and those who chronically consume pain medication.

What data supports the effectiveness of the treatment PrO2Fit Device, PrO2Fit Device, Inspiratory Muscle Trainer for exercise-induced asthma?

Inspiratory muscle training (IMT) has been shown to improve muscle strength and endurance in asthma patients, leading to better asthma symptoms, fewer hospital visits, and reduced medication use. Studies also show that similar devices and training methods can enhance exercise capacity and quality of life in patients with respiratory conditions.12345

Is inspiratory muscle training safe for humans?

Inspiratory muscle training (IMT) has been studied in various conditions like chronic obstructive pulmonary disease (COPD) and asthma, and it is generally considered safe. Studies have shown positive effects on muscle function and breathing without significant safety concerns.12678

How does the PrO2Fit Device treatment for exercise-induced asthma differ from other treatments?

The PrO2Fit Device is unique because it focuses on strengthening the respiratory muscles through inspiratory muscle training, which involves breathing against resistance to improve muscle strength and endurance. This approach is different from typical asthma treatments that often rely on medications to open airways or reduce inflammation.145910

Research Team

TM

Tim Mickleborough, Ph.D.

Principal Investigator

Indiana University

Eligibility Criteria

This trial is for competitive recreational or college athletes aged 18-35 with mild to moderate persistent asthma or EIB, a BMI of 18.5-28, and at least 1-2 years of cycling experience. They must have an FEV1 >65% predicted and not be on asthma maintenance meds, SSRIs, ADHD meds, painkillers regularly, fish oil supplements, nor have cardiovascular or other specified diseases.

Inclusion Criteria

Required to be a competitive recreational or college athlete with at least 1-2 years of cycling or biking experience
Body Mass Index (BMI) of 18.5 to 28 kg/m^2
I have asthma or EIB, but can still breathe relatively well.
See 4 more

Exclusion Criteria

Resting Pulse rate of > 100 bpm
I have a history of smoking or have had heart, kidney, brain, or metabolic diseases.
I am currently on asthma maintenance medication.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo inspiratory muscle training (IMT) or sham IMT for 8 weeks, focusing on improving inspiratory muscle strength and endurance.

8 weeks
3 sessions per week

Follow-up

Participants are monitored for changes in exercise-induced bronchoconstriction severity, inspiratory muscle strength, and cycling performance.

4 weeks

Treatment Details

Interventions

  • PrO2Fit Device
Trial Overview The study tests if inspiratory muscle training (IMT) using the PrO2Fit Device can reduce the severity of exercise-induced bronchoconstriction (EIB), lessen short-acting beta-agonist use, improve lung function and oxygenation during exercise, decrease breathlessness and enhance time-trial cycling performance in athletes.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Inspiratory Muscle Training (IMT) groupExperimental Treatment1 Intervention
The test protocol requires participants to inhale maximally (maximum inspiratory pressure, MIP) against 2mm diameter leak and sustain inhalation (sustained maximal inspiratory pressure, SMIP) until task failure. Participants will complete 3 SMIP maneuvers with each training session and use the best of the three for that day's training template (corresponding to about 80% SMIP for the IMT group) via the PrO2Fit software. Participants must match or exceed the SMIP template with each increasing level of the work-rest ratio. Work at each level consists of 6 breaths, 36 breaths total. If six breaths are completed, the next level starts. Rest intervals will progressively shorten as training continues from 40-seconds to 5-seconds. The session will be terminated if participants are unable to match at least 90% of the training template for two consecutive breaths or have completed all 36 breaths. Training will be done 3 times a week, and over 8-weeks.
Group II: Sham Inspiratory Muscle Training (Sham-IMT) groupPlacebo Group1 Intervention
Similar to the IMT group protocol, participants will be required to complete 3 SMIP maneuvers with each training session. Participants will use the best of the three for that day's training template (corresponding to about 30% SMIP for the Sham-IMT group) via the PrO2Fit software. Participants must match or exceed the SMIP template with each increasing level of the work-rest ratio. Work at each level consists of 6 breaths, 36 breaths total. If six breaths are completed, the next level starts. Rest intervals will progressively shorten as training continues from 40-seconds to 30-, 20-, 15-, 10-, and 5-seconds. The training session will be terminated if participants are unable to match at least 90% of the training template for two consecutive breaths or have completed all 36 breaths. Training will be done 3 times a week, and over 8-weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

Findings from Research

Inspiratory muscle training (IMT) has been shown to improve inspiratory muscle function in patients with chronic obstructive pulmonary disease (COPD), with most studies indicating positive effects when proper training methods are used.
IMT can lead to significant clinical benefits, including reduced dyspnea and increased exercise capacity, as evidenced by improved walking distances in 6 or 12-minute tests, particularly when using a threshold device at an intermediate load for at least 5 weeks.
[Inspiratory muscle training in patients with chronic obstructive pulmonary disease].Lisboa, C., Borzone, G., Cruz, E.[2006]
Inspiratory muscle training (IMT) significantly improved muscle strength and peak expiratory flow (PEF) in children with asthma, with MIP increasing from -48.32 to -109.92 and PEF from 173.6 to 312, indicating enhanced respiratory function.
In contrast, the control group showed no significant improvements in muscle strength, highlighting the efficacy of IMT and respiratory exercises in reducing asthma severity and improving respiratory muscle efficiency.
Inspiratory muscle training and respiratory exercises in children with asthma.Lima, EV., Lima, WL., Nobre, A., et al.[2019]
In a study involving 300 asthma patients aged 55-60, both a conventional threshold loading device and an innovative respiratory training device showed significant improvements in exercise performance and pulmonary function after 10 weeks of lower torso sports training.
The new respiratory training device was found to be as effective as the conventional device, indicating that both methods can beneficially enhance respiratory training combined with athletic training for asthma patients.
The Effect of Threshold Loading Training and an Innovative Respiratory Training Devices with Lower Torso Sports Training in Asthma Patients: A Randomized Trial.Hamad, SH., Hadi, AH., Mohr, M., et al.[2023]

References

[Inspiratory muscle training in patients with chronic obstructive pulmonary disease]. [2006]
Inspiratory muscle training and respiratory exercises in children with asthma. [2019]
The Effect of Threshold Loading Training and an Innovative Respiratory Training Devices with Lower Torso Sports Training in Asthma Patients: A Randomized Trial. [2023]
Inspiratory Muscle Training in Patients with Chronic Obstructive Pulmonary Disease (COPD) as Part of a Respiratory Rehabilitation Program Implementation of Mechanical Devices: A Systematic Review. [2023]
[Inspiratory muscle training for bronchial asthma]. [2006]
Measurement validity of an electronic training device to assess breathing characteristics during inspiratory muscle training in patients with weaning difficulties. [2021]
The effect of inspiratory muscle training in PCD and CF patients: A pilot study. [2023]
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD). [2023]
Inspiratory muscle training improves the swimming performance of competitive young male sprint swimmers. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Inspiratory muscle training: integrative review of use in conditions other than COPD. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security